Hillsdale Investment Management Inc. Ani Pharmaceuticals Inc Transaction History
Hillsdale Investment Management Inc.
- $1.13 Billion
- Q1 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 67,510 shares of ANIP stock, worth $4.15 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
67,510
Previous 69,410
2.74%
Holding current value
$4.15 Million
Previous $3.83 Million
21.92%
% of portfolio
0.41%
Previous 0.33%
Shares
4 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
14MCall Options Held
26.7KPut Options Held
237K-
Black Rock Inc. New York, NY2.53MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$80.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY959KShares$58.9 Million2.26% of portfolio
-
Deep Track Capital, LP Greenwich, CT822KShares$50.5 Million1.88% of portfolio
-
Dimensional Fund Advisors LP Austin, TX609KShares$37.4 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.07B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...